Showing 231-240 of 1560 results for "".
Evaluating Biomarkers at Work in NSCLC
https://reachmd.com/programs/project-oncology/evaluating-biomarkers-at-work-in-nsclc/12522/What are some of the challenges that come with using biomarkers to treat non-small cell lung cancer?AEGEAN Trial: The Role of Perioperative Durvalumab in NSCLC
https://reachmd.com/programs/project-oncology/aegean-trial-the-role-of-perioperative-durvalumab-in-nsclc/16500/Explore the results of the AEGAN trial that focused on the use of neoadjuvant durvalumab in non-small cell lung cancer care.CDC and Diabetes: Early Detection and Prevention
https://reachmd.com/programs/clinicians-roundtable/cdc-and-diabetes-early-detection-and-prevention/1775/Diabetes translation brings research data into the clinical practice. In this segment join host Bill Rutenberg, MD and guest Ann Albright, Ph.D. in a discussion about early diabetes detection and prevention, and how the CDC is working to stem the tide of the diabetes epidemic.Advancing Care in Locally Advanced HNSCC: Integrating Perioperative Immunotherapy and Multimodal Strategies
https://reachmd.com/programs/cme/advancing-care-in-locally-advanced-hnscc-integrating-perioperative-immunotherapy-and-multimodal-strategies/35704/Explore perioperative immunotherapy and multimodal strategies to optimize patient outcomes in resectable locally advanced head and neck squamous cell carcinoma.Treating Gastrointestinal Neuroendocrine Carcinoma: Beyond Lung-Based Approaches
https://reachmd.com/programs/project-oncology/treating-gastrointestinal-neuroendocrine-carcinoma-beyond-lung-based-approaches/36455/Gastrointestinal neuroendocrine carcinomas have historically been treated like small cell neuroendocrine carcinoma of the lung or small cell lung cancer because of their similar morphology. However, emerging data reveal distinct molecular differences, underscoring the need for tailored therapeutic sTILplus Score as a Potential Predictive Biomarker in First-Line ICI Therapy for mccRCC
https://reachmd.com/programs/project-oncology/tilplus-score-as-a-potential-predictive-biomarker-in-first-line-ici-therapy-for-mccrcc/33001/Can histopathology help predict response to immunotherapy in metastatic clear cell renal cell carcinoma (mccRCC)? A new retrospective study presented at ASCO 2025 suggests that TILplus—a simple scoring system based on immune infiltrate proximity in H&E-stained metastatic tissue—may serve as a vaThe Subtle Threats of Benzene on Airway Health: Insights from an In Vitro ALI Model
https://reachmd.com/programs/clinicians-roundtable/the-subtle-threats-of-benzene-on-airway-health-insights-from-an-in-vitro-ali-model/35658/A recent study published in the American Journal of Respiratory and Critical Care Medicine found that sub-cytotoxic benzene exposure can disrupt oxidative stress signaling and immune cell chemotaxis in airway epithelial cells without activating typical inflammatory of metabolic pathways. Read aboutA Cancer Survivor MD's Work in Ped. Pulmonology
https://reachmd.com/programs/clinicians-roundtable/a-cancer-survivor-mds-work-in-ped-pulmonology/1171/Join Dr. Geoffrey Kurland as he describes how he treats his pediatric patients differently because of his own battle with Hairy Cell Leukemia.Exploring the Effect of Triglycerides
https://reachmd.com/programs/heart-matters/exploring-the-effect-of-triglycerides/12264/Do triglycerides have a direct effect on our endothelial cells or have a more indirect effect by changing our LDL cholesterol?The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
https://reachmd.com/programs/project-oncology/the-potential-impact-of-rcc-molecular-subtypes-on-treatment-outcomes/26533/Tune in to hear expert insights on recent research investigating if renal cell carcinoma molecular subtypes impact treatment outcomes.